Choose your country to see the products for your location

SALSA MLPA Probemix P047 RB1

Retinoblastoma (RB)

Region: RB1 13q14.2

General information
The SALSA MLPA Probemix P047 RB1 is a research use only (RUO) assay for the detection of deletions or duplications in the RB1 gene and of methylation status of the RB1 gene promoter and imprinted locus in a DNA sample.

Retinoblastoma (RB; OMIM180200) is an embryonic neoplasm of retinal origin developing in early childhood and often bilaterally. The incidence of RB is estimated between 1:15000 and 1:20000 live births (Moll et al. 1997, Seregard et al. 2004). Retinoblastomas occur in two forms: hereditary and non-hereditary (sporadic), representing about 40 and 60% of all RB cases, respectively. In hereditary RB, germline mutations causing RB1 gene loss or inactivation are inherited in autosomal dominant pattern and predispose to RB development with high penetrance. Over 80% of hereditary RB is caused by de novo RB1 mutations arising during embryonic development. Bilateral and unilateral hereditary RB represent about 25-30% and 10-15% of all RB cases, respectively. None of the sporadic RBs is bilateral. Bilateral RB patients also have a predisposition for secondary cancers with the highest risk for osteosarcomas. In about 1.5% of unilateral RB cases somatic MYCN amplification (but no RB1 pathogenic variants) was detected (Rushlow et al. 2013).

The RB1 gene (27 exons) located on 13q14.2 spans about 180 kb of genomic DNA and is a well characterized tumour suppressor gene encoding a ubiquitously expressed nuclear protein involved in cell cycle regulation, cellular differentiation and survival. Point mutations, small and large deletions, as well as promoter methylation in the RB1 gene affect the function of retinoblastoma-associated protein (pRB). Over 500 pathogenic germline variants were identified in the RB1 gene (https://databases.lovd.nl/shared/variants/RB1/). Moreover, additional clinical features were described for deletions at 13q14 encompassing the RB1 gene (Mitter et al. 2011), such as RB1 gene deletions spanning to the PCDH8 gene have been shown to play an important role in psychomotor delay in RB patients (Castera et al. 2013, Mitter et al. 2011). Contiguous loss of MED4, which is located centromeric to RB1 is thought to contribute to synthetic lethality in cells with RB1 homozygous loss (Dehainault et al. 2014).

pRB loss, predominantly via heterozygous deletion of RB1 gene, is also a common abnormality for various cancer types, including breast cancer, lung cancer, prostate cancer and osteosarcoma, and is often associated with poor survival (reviewed in Mandigo et al. 2021).

RB1 inactivation by methylation of promoter region (CpG106) has been shown in 8-15% RB (Dommering et al. 2014, Greger et al. 1989, Price et al. 2014) and in other cancers (Sahi et al. 2014, Simpson et al. 2000). Moreover, an imprinted locus in intron 2 of the RB1 gene (CpG85) - methylated at the maternal allele, has been identified (Kanber et al. 2009), and recently the importance of the methylation of this imprinted locus in hepatocellular carcinoma has been shown (Anwar et al. 2014).

More information is available at https://www.ncbi.nlm.nih.gov/books/NBK1452/.

This SALSA MLPA probemix is not CE/FDA registered for use in diagnostic procedures. Purchase of this product includes a limited license for research purposes.

Probemix content
The SALSA MLPA Probemix P047-E2 RB1 contains 57 (MS-)MLPA probes with amplification products between 129 and 500 nucleotides (nt). This includes 35 probes for RB1 covering all exons, except exon 15 which is located at a close distance to the adjacent exons, of which five MS-MLPA probes target the RB1 promoter region (CpG106) and three MS-MLPA probes target the imprinted CpG island in intron 2 (CpG85). These MS-MLPA probes contain an HhaI recognition site and provide information on the methylation status of selected GCGC sites in CpG106 and CpG85.

In addition, 13 reference probes are included that are not affected by HhaI digestion and target relatively copy number stable regions in various cancer types. Also, one digestion control probe is included in this probemix indicating whether or not restriction endonuclease digestion in the MS-MLPA reaction was complete. Complete probe sequences are available online (https://www.mrcholland.com).
This probemix contains nine quality control fragments generating amplification products between 64 and 105 nt: four DNA Quantity fragments (Q-fragments), two DNA Denaturation fragments (D-fragments), one Benchmark fragment, and one chromosome X- and one chromosome Y-specific fragment (see table below). More information on how to interpret observations on these control fragments can be found in the (MS-)MLPA General Protocol and online at https://www.mrcholland.com.

Order Items

Probemix

Item no.
Description
Technology
Price
P047-025R
SALSA MLPA Probemix P047 RB1 – 25 rxn
€ 260.00
P047-050R
SALSA MLPA Probemix P047 RB1 – 50 rxn
€ 510.00
P047-100R
SALSA MLPA Probemix P047 RB1 – 100 rxn
€ 998.00

Required Reagents (Sold Separately)

Item no.
Description
Technology
Price
EK1-FAM
SALSA MLPA Reagent Kit – 100 rxn – FAM
€ 316.00
EK1-Cy5
SALSA MLPA Reagent Kit – 100 rxn – Cy5
€ 316.00
EK5-FAM
SALSA MLPA Reagent Kit – 500 rxn – FAM
€ 1455.00
EK5-Cy5
SALSA MLPA Reagent Kit – 500 rxn – Cy5
€ 1455.00
EK20-FAM
SALSA MLPA Reagent Kit – 2000 rxn – FAM
€ 5590.00

Related Products

SALSA MLPA Probemix P037 CLL-1

Contain RB1 probes, respectively, in the context of 13q14 deletion detection in chronic lymphocytic leukaemia.

SALSA MLPA Probemix P038 CLL-2

Contain RB1 probes, respectively, in the context of 13q14 deletion detection in chronic lymphocytic leukaemia.

SALSA MLPA Probemix P040 CLL

Contain RB1 probes, respectively, in the context of 13q14 deletion detection in chronic lymphocytic leukaemia.

SALSA MLPA Probemix P175 Tumour Gain

Contains two probes for MYCN gene found amplified in RB, as well as probes targeting frequently gained genes and chromosomal regions in various cancers, and one probe specific for BRAF p.V600E mutation.

SALSA MLPA Probemix P252 NB mix 2

Contains two probes for MYCN gene found amplified in RB, as well as probes targeting frequently deleted or gained genes and chromosomal regions in neuroblastomas.

SALSA MLPA Probemix P294 Tumour Loss

Contains two RB1 probes (exon 3 and 25), as well as probes targeting frequently deleted genes and chromosomal regions in various cancers.

SALSA MLPA Probemix P335 ALL-IKZF1

Contains five RB1 probes (exon 6, 14, 19, 24 and 26), as well as multiple probes for the detection of deletions of the IKZF1 gene and copy number determination of PAX5, ETV6, BTG1, EBF1, CDKN2A, CDKN2B genes and PAR1 region in acute lymphoblastic leukemia.

SALSA MLPA Probemix P377 Hematologic Malignancies

Contains two RB1 probes (exon 23 and 27), as well as probes for several genes and chromosomal regions known to have a significant diagnostic or prognostic role in hematologic malignancies, and one probe specific for JAK2 p.V617F mutation.

SALSA MLPA Probemix P425 Multiple Myeloma

Contains two RB1 probes (exon 8 and 26) in the context of 13q14-q22 deletion detection in multiple myeloma.

Sign in

Don't have an account? Create one

Forgot password?

Select Your Country

Choose your country to see the products for your location